序号 | 股票 | 持股数量(万股) | 持股变动 | 股份性质 | 占总股本比例 | 报告期 |
1 | 汇宇制药 | 1269.56 | 未变 | 流通A股 | 3% | 2024-09-30 |
2 | 汇宇制药 | 1269.56 | 未变 | 流通A股 | 3% | 2024-06-30 |
3 | 汇宇制药 | 1269.56 | 未变 | 流通A股 | 3.02% | 2024-03-31 |
4 | 汇宇制药 | 1269.56 | 未变 | 流通A股 | 3% | 2024-02-23 |
5 | 汇宇制药 | 1269.56 | 未变 | 流通A股 | 3% | 2023-12-31 |
6 | 汇宇制药 | 1269.56 | 未变 | 流通A股 | 3% | 2023-09-30 |
7 | 汇宇制药 | 1269.56 | 减持 | 流通A股 | 3% | 2023-06-30 |
8 | 汇宇制药 | 2131.38 | 未变 | 流通A股 | 5.03% | 2023-03-31 |
9 | 汇宇制药 | 2131.38 | 减持 | 流通A股 | 5.03% | 2023-02-17 |
10 | 汇宇制药 | 4250.38 | 减持 | 流通A股 | 10.03% | 2023-02-08 |
11 | 汇宇制药 | 4516.21 | 减持 | 流通A股 | 10.66% | 2022-12-31 |
12 | 汇宇制药 | 5519.36 | 未变 | 限售流通股 | 13.03% | 2022-09-30 |
13 | 汇宇制药 | 5519.36 | 未变 | 限售流通股 | 13.03% | 2022-06-30 |
14 | 汇宇制药 | 5519.36 | 未变 | 限售流通股 | 13.03% | 2022-03-31 |
15 | 汇宇制药 | 5519.36 | 未变 | 限售流通股 | 13.03% | 2021-12-31 |
16 | 汇宇制药 | 5519.36 | 未变 | 13.03% | 2021-10-26 | |
17 | 汇宇制药 | 5519.36 | 未变 | 限售流通股 | 15.33% | 2021-10-12 |
18 | 汇宇制药 | 5519.36 | 新进 | 限售流通股 | 15.33% | 2020-12-02 |
序号 | 股票 | 持股数量(万股) | 持股变动 | 股份性质 | 占总股本比例 | 报告期 |
1 | 汇宇制药 | 1269.56 | 未变 | 境内法人股 | 4.361% | 2024-09-30 |
2 | 汇宇制药 | 1269.56 | 未变 | 境内法人股 | 4.361% | 2024-06-30 |
3 | 汇宇制药 | 1269.56 | 未变 | 境内法人股 | 4.361% | 2024-03-31 |
4 | 汇宇制药 | 1269.56 | 未变 | 境内法人股 | 4.361% | 2024-02-23 |
5 | 汇宇制药 | 1269.56 | 未变 | 境内法人股 | 4.361% | 2023-12-31 |
6 | 汇宇制药 | 1269.56 | 未变 | 境内法人股 | 4.389% | 2023-09-30 |
7 | 汇宇制药 | 1269.56 | 减持 | 境内法人股 | 4.389% | 2023-06-30 |
8 | 汇宇制药 | 2131.38 | 减持 | A股 | 7.37% | 2023-03-31 |
9 | 汇宇制药 | 4516.21 | 新进 | 境内法人股 | 15.615% | 2022-12-31 |
序号 | 股东 | 股票 | 变动日期 | 职位 | 变动前持股数 | 变动数 | 变动后持股数 | 变动人 | 关系 |